▽The New England Journal of Medicine: Research & Review Articles on Diseases & Clinical Practice ●11/20 16:14 Nov 18, 2024Meeting of the American Heart AssociationAAV9.LAMP2B Gene Therapy for Danon DiseaseB. Greenberg and OthersIn a study involving patients with Danon disease, AAV9.LAMP2B gene therapy appeared to be safe, increased cardiac LAMP2 expression, and was associated with clinical improvement over 24 to 54 months.Listen here: NEJM at AHA — Phase 1 Study of AAV9.LAMP2B Gene Therapy in Danon D
▽bmj.com: BMJ - Helping doctors make better decisions ●11/16 12:26 Quality care is needed for older people with diabetes in care homes—now and for the futureAlberta Health Services: Radiation Oncologist, Tom Baker Cancer Centre, CalgaryAlberta Health Services: Hematologist in Medical Oncology, Cross Cancer Institute (CCI), EdmontonUniversity Hospitals Plymouth NHS Trust: Consultant Cardiothoracic AnaesthetistUniversity Hospitals Plymouth NHS Trust: Consultant